Wearable Technology and Blood Pressure Monitoring: Addressing the Global Hypertension Problem
High blood pressure (BP) is a global health tragedy and there is tremendous potential public health value in getting more people to measure their BP more often. According to the World Health Organization, over one billion people around the world have hypertension and in the US the CDC estimates one-third of those with hypertension don’t even know it. Additionally, hypertension is the single biggest risk factor for all global disease. It ranks above smoking, high blood sugar, and high BMI. There are no outward, visible signs or symptoms as a person moves towards hypertension and for this reason, it is often called the “silent killer.” Compounding the problem is the fact that BP cuffs are hard to use and they come with a stigma.
Valencell has created the world’s first wearable, cuffless blood pressure monitoring technology that does NOT require calibration AND provide cuff-like performance without a cuff. Embedded in an earbud reference design, the technology has demonstrated BP cuff-like accuracy through rigorous testing on thousands of patients and tens of thousands of datasets. The technology can recognize hypertension with 89% accuracy, which is more accurate than comparable technologies available today and provides BP readings within +/-8mmHg for qualified datasets. Valencell has published a white paper summarizing clinical study results conducted in the fall of 2019 and those results are available here: https://valencell.com/blog/2020/01/validation-data-for-valencell-calibration-free-blood-pressure-technology/
In this session, Dr. Steven LeBoeuf will discuss the details of how this BP technology works, the results of validation studies demonstrating the efficacy of the technology, how it is being integrated in devices today, and what’s next on the horizon for cuffless BP monitoring.